MP
member/Executive/Associated Person Other
DK DK · Finanstilsynet DK
Browse the detailed record of transactions filed by member/Executive/Associated Person. Insider active across 3 companies, notably Novo Nordisk A/S. Cumulatively, 114 disclosures have been published. The latest transaction was filed on 7 May 2026 — Gift. Regulator: Finanstilsynet DK. All data is openly available.
Declarations 114 total
DKK 1,969 50 shares @ DKK 39.3812 100.0% of flow DK0062498333⌘
Share Outside a trading venueDK:1441704 · 7 May 2026
€1m 26,246 shares @ €42.2402 0.0% of flow DK0062498333⌘
Share JANE STREET NETHERLANDS B.V.DK:1419574 · 10 Feb 2026
€941,919 22,000 shares @ €42.8145 0.0% of flow DK0062498333⌘
DK:1419156 · 9 Feb 2026
01,085 shares 0DK0062498333⌘
Share Outside a trading venueDK:1418330 · 4 Feb 2026
€269,894 6,450 shares @ €41.8441 0.0% of flow DK0062498333⌘
DK:1401014 · 17 Nov 2025
Ideal exit: 14 Aug 2026 (T+270) 018,634 shares 0DK0062498333⌘
Share Outside a trading venueDK:1399962 · 10 Nov 2025
€44,518 952 shares @ €46.7629 0.0% of flow
Share New York Stock ExchangeDK:1384043 · 18 Aug 2025
Ideal exit: 15 May 2026 (T+270) €524,028 12,000 shares @ €43.669 0.0% of flow DK0062498333⌘
DK:1382865 · 8 Aug 2025
€1m 28,710 shares @ €39.5164 0.0% of flow DK0062498333⌘
DK:1382513 · 7 Aug 2025
€3,140 74 shares @ €42.4299 0.0% of flow DK0062498333⌘
DK:1382344 · 7 Aug 2025
€1m 20,000 shares @ €59.6148 0.0% of flow DK0062498333⌘
DK:1362269 · 7 May 2025
€3m 40,000 shares @ €83.1334 0.1% of flow DK0062498333⌘
DK:1341672 · 6 Feb 2025
01,407 shares 0DK0062498333⌘
Share Outside a trading venueDK:1341302 · 5 Feb 2025
€237,712 2,500 shares @ €95.0849 0.0% of flow
Share New York Stock ExchangeDK:1328724 · 18 Nov 2024
Ideal exit: 15 Aug 2025 (T+270) €129,534 1,300 shares @ €99.6414 0.0% of flow
Share New York Stock ExchangeDK:1327620 · 12 Nov 2024
Ideal exit: 9 Aug 2025 (T+270) 018,634 shares 0DK0062498333⌘
Share Outside a trading venueDK:1327424 · 11 Nov 2024
€141,352 1,400 shares @ €100.9657 0.0% of flow
Share New York Stock ExchangeDK:1326827 · 6 Nov 2024
Ideal exit: 3 Aug 2025 (T+270) €130,881 1,400 shares @ €93.4866 0.0% of flow
Share New York Stock ExchangeDK:1326582 · 6 Nov 2024
Ideal exit: 3 Aug 2025 (T+270) €1,545 12.742 shares @ €121.2407 0.0% of flow
Share New York Stock ExchangeDK:1313875 · 28 Aug 2024
Ideal exit: 25 May 2025 (T+270) Share New York Stock ExchangeDK:1311855 · 20 Aug 2024
Ideal exit: 17 May 2025 (T+270) €1m 8,480 shares @ €119.9925 0.0% of flow DK0062498333⌘
DK:1310732 · 13 Aug 2024
€1,314 11 shares @ €119.4146 0.0% of flow DK0062498333⌘
DK:1310299 · 9 Aug 2024
Ideal exit: 6 May 2025 (T+270) €22,890 208.385 shares @ €109.8441 0.0% of flow
Share New York Stock ExchangeDK:1310156 · 7 Aug 2024
Ideal exit: 4 May 2025 (T+270) €40 37 shares @ €1.0719 0.0% of flow DK0062498333⌘
Share New York Stock ExchangeDK:1309977 · 8 Aug 2024
Ideal exit: 5 May 2025 (T+270) €1m 9,000 shares @ €122.6953 0.0% of flow DK0062498333⌘
DK:1295786 · 14 May 2024
25 of 114 declarations
Load more (89 remaining) About member/Executive/Associated Person Member, Director at Novo Nordisk A/S.